Literature DB >> 18019041

Outcomes of public concern in schizophrenia.

Iain Kooyman1, Kimberlie Dean, Samuel Harvey, Elizabeth Walsh.   

Abstract

BACKGROUND: Schizophrenia is known to be associated with a range of adverse outcomes, which have an impact atthe societal level and are therefore of public concern. AIMS: To examine the epidemiology and methods for measuring six adverse outcomes in schizophrenia: violence, victimisation, suicide/self-harm, substance use, homelessness and unemployment.
METHOD: A review ofthe literature was carried out for each adverse outcome, with attention to critical appraisal of existing measurement tools.
RESULTS: Schizophrenia is associated strongly with all six outcomes, although research has mainly focused on violence. Each outcome acts as a risk factor for at least some of the other outcomes. There are few standardised or validated measures for these 'hard' outcomes. Each measure has inherent biases but a growing trend is for these to be minimised by using multiple measures.
CONCLUSIONS: A single instrument which systematically measures multiple societal outcomes of schizophrenia would be extremely useful for both clinical and research purposes.

Entities:  

Mesh:

Year:  2007        PMID: 18019041     DOI: 10.1192/bjp.191.50.s29

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


  25 in total

1.  Taking Stock and Taking Steps: The Case for an Adolescent Version of the Short-Assessment of Risk and Treatability.

Authors:  Jodi L Viljoen; Keith R Cruise; Tonia L Nicholls; Sarah L Desmarais; Christopher Webster
Journal:  Int J Forensic Ment Health       Date:  2012-11-06

2.  Assessment of Multiple Risk Outcomes, Strengths, and Change with the START:AV: A Short-Term Prospective Study with Adolescent Offenders.

Authors:  Jodi L Viljoen; Jennifer L Beneteau; Erik Gulbransen; Etta Brodersen; Sarah L Desmarais; Tonia L Nicholls; Keith R Cruise
Journal:  Int J Forensic Ment Health       Date:  2012-11-06

Review 3.  Work and common psychiatric disorders.

Authors:  M Henderson; S B Harvey; S Overland; A Mykletun; M Hotopf
Journal:  J R Soc Med       Date:  2011-05       Impact factor: 5.344

4.  Using dynamic risk and protective factors to predict inpatient aggression: reliability and validity of START assessments.

Authors:  Sarah L Desmarais; Tonia L Nicholls; Catherine M Wilson; Johann Brink
Journal:  Psychol Assess       Date:  2012-01-16

5.  Schizophrenia--time to commit to policy change.

Authors:  W Wolfgang Fleischhacker; Celso Arango; Paul Arteel; Thomas R E Barnes; William Carpenter; Ken Duckworth; Silvana Galderisi; Lisa Halpern; Martin Knapp; Stephen R Marder; Mary Moller; Norman Sartorius; Peter Woodruff
Journal:  Schizophr Bull       Date:  2014-04       Impact factor: 9.306

6.  Burden for Parents of Patients With Schizophrenia-A Nationwide Comparative Study of Parents of Offspring With Rheumatoid Arthritis, Multiple Sclerosis, Epilepsy, and Healthy Controls.

Authors:  Ellenor Mittendorfer-Rutz; Syed Rahman; Antti Tanskanen; Maila Majak; Juha Mehtälä; Fabian Hoti; Erik Jedenius; Dana Enkusson; Amy Leval; Jan Sermon; Heidi Taipale; Jari Tiihonen
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 9.306

7.  Metastatic breast cancer in patients with schizophrenia.

Authors:  Aaron A Meyer; M Hwang; M Farasatpour; R Janardhan; J A Margenthaler; K S Virgo; Frank E Johnson
Journal:  Mol Clin Oncol       Date:  2012-11-27

8.  Violent crime, suicide, and premature mortality in patients with schizophrenia and related disorders: a 38-year total population study in Sweden.

Authors:  Seena Fazel; Achim Wolf; Camilla Palm; Paul Lichtenstein
Journal:  Lancet Psychiatry       Date:  2014-06       Impact factor: 27.083

9.  Lost working years due to mental disorders: an analysis of the Norwegian disability pension registry.

Authors:  Ann Kristin Knudsen; Simon Øverland; Matthew Hotopf; Arnstein Mykletun
Journal:  PLoS One       Date:  2012-08-15       Impact factor: 3.240

10.  Antipsychotics, mood stabilisers, and risk of violent crime.

Authors:  Seena Fazel; Johan Zetterqvist; Henrik Larsson; Niklas Långström; Paul Lichtenstein
Journal:  Lancet       Date:  2014-05-08       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.